CHLA-218Homo sapiens (Human)Cancer cell line

Also known as: CHLA218

🤖 AI SummaryBased on 1 publications

Quick Overview

Human cell line with STAG2 mutations linked to Ewing sarcoma.

Detailed Summary

CHLA-218 is a human cell line associated with Ewing sarcoma, characterized by mutations in the STAG2 gene. These mutations are frequently observed in Ewing sarcoma family of tumors (EFT) and are linked to altered molecular profiles. The cell line is part of a study that identified recurrent STAG2 mutations in EFT, highlighting its relevance in understanding the genetic basis of this cancer. Research on CHLA-218 contributes to the exploration of molecular mechanisms and potential therapeutic targets in Ewing sarcoma.

Research Applications

Ewing sarcoma researchSTAG2 mutation analysisGenomic profiling of tumors

Key Characteristics

STAG2 mutationsEwing sarcoma association
Generated on 6/15/2025

Basic Information

Database IDCVCL_0B48
SpeciesHomo sapiens (Human)

Donor Information

Age CategoryUnknown
SexFemale

Disease Information

DiseasePrimitive neuroectodermal tumor
LineageBone
SubtypeEwing Sarcoma
OncoTree CodeES

DepMap Information

Source TypeAcademic lab
Source IDACH-001030_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
8,11
D16S539
12
D18S51
11,13
D19S433
13,16
D21S11
29,31
D2S1338
23
D3S1358
16
D5S818
11,12
D7S820
10
D8S1179
8,13
FGA
21,24
TH01
7
TPOX
8,11
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation.

Catchpoole D., Llombart-Bosch A., Waldman T., Khan J.

PLoS Genet. 10:E1004475-E1004475(2014).

Web Resources